REDUCED INTENSITY/NON-MYELOABLATIVE ALLOGRAFTING FOR HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Giaccone, L. [1 ]
Sorasio, R. [1 ]
Fiore, F. [1 ]
Bergui, L. [1 ]
Resta, I [1 ]
Omede, P. [1 ]
Caltagirone, S. [1 ]
Massaia, M. [1 ]
Boccadoro, M. [1 ]
Bruno, B. [1 ]
机构：
[1] Univ Torino, Azienda Osped San Giovanni Battista, Div Ematol, Turin, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P148
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [1] Molecular remissions after non-myeloablative allografting for chronic myelocytic leukemia (CML).
    McSweeney, P
    Niederwieser, D
    Shizuru, J
    Radich, J
    Molina, A
    Hegenbart, U
    Chauncey, T
    Sandmaier, B
    Wolff, D
    Blume, K
    Storb, R
    BLOOD, 1999, 94 (10) : 710A - 710A
  • [2] Hematopoietic Stem Cell Allografting for Chronic Lymphocytic Leukemia: A Focus on Reduced-Intensity Conditioning Regimens
    Kharfan-Dabaja, Mohamed A.
    Bazarbachi, Ali
    CANCER CONTROL, 2012, 19 (01) : 68 - 75
  • [3] REDUCED INTENSITY VERSUS FULL MYELOABLATIVE STEM CELL TRANSPLANT FOR ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
    Peres, E.
    Levine, J.
    Kato, K.
    Krijanovski, O.
    Khaled, Y.
    Ferrara, J.
    Yanik, G.
    Mineishi, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 62 - 62
  • [4] Outpatient allografting using non-myeloablative conditioning: the Mexican experience
    O G Cantú-Rodríguez
    J C Jaime-Pérez
    C H Gutiérrez-Aguirre
    O González-Llano
    C Mancías-Guerra
    L C Tarín-Arzaga
    G J Ruiz-Delgado
    C C Sandoval-Villa
    J Marfil-Rivera
    A Morales-Toquero
    G J Ruiz-Argüelles
    D Gómez-Almaguer
    Bone Marrow Transplantation, 2007, 40 : 119 - 123
  • [5] SAFETY AND CLINICAL EFFICACY OF EARLY VACCINATION AFTER NON-MYELOABLATIVE TRANSPLANT FOR ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
    Wu, C. J.
    Hainz, U.
    Stevenson, K. E.
    Goldstein, N. P.
    Brusic, A. M.
    Choi, J. J.
    Pasek, M.
    Brown, J. R.
    Canning, C. M.
    Armand, P. J.
    Koreth, J.
    Cutler, C.
    Soiffer, R. J.
    Sasada, T.
    Ritz, J.
    Dranoff, G.
    Alyea, E. P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S164 - S164
  • [6] Outpatient allografting using non-myeloablative conditioning:: the Mexican experience
    Cantu-Rodriguez, O. G.
    Jaime-Perez, J. C.
    Gutierez-Aguirre, C. H.
    Gonzalez-Llano, O.
    Mancias-Guerra, C.
    Tarin-Arzaga, L. C.
    Ruiz-Delgado, G. J.
    Sandoval-Villa, C. C.
    Marfill-Rivera, J.
    Morales-Toquero, A.
    Ruiz-Arguelles, G. J.
    Gomez-Almaguer, D.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 119 - 123
  • [7] Stem cell allografting using a non-myeloablative regimen.
    Tan, P
    Tee, GY
    BLOOD, 1996, 88 (10) : 449 - 449
  • [8] Autografting followed by non-myeloablative allografting (NST) induces high complete remissions in high risk multiple myeloma.
    Beltrami, G
    Corsetti, MT
    Musto, P
    Carella, AM
    Scalzulli, PR
    Greco, MM
    Lerma, E
    Carella, AM
    BLOOD, 2002, 100 (11) : 622A - 622A
  • [9] Comparative Outcome of Myeloablative and Reduced Intensity Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
    Brown, Jennifer R.
    Stevenson, Kristen
    Kim, Haesook T.
    Armand, Philippe
    Cutler, Corey
    Fisher, David C.
    Ho, Vincent
    Koreth, John
    Ritz, Jerome
    Antin, Joseph H.
    Soiffer, Robert J.
    Gribben, John G.
    Alyea, Edwin
    BLOOD, 2008, 112 (11) : 357 - 358
  • [10] Non-myeloablative allogeneic transplantation for high-risk acute leukemia and myelodysplasia.
    Peggs, K
    Craddock, C
    Milligan, D
    Chopra, R
    Mahendra, P
    Chakraverty, R
    Hunter, A
    Parker, A
    Pettengell, R
    Vandenberghe, E
    Hale, G
    Waldmann, H
    Kottaridis, P
    Morris, E
    Goldstone, A
    Linch, D
    Mackinnon, S
    BLOOD, 2001, 98 (11) : 410A - 411A
12345